Does LEUPROLIDE Cause Ovarian hyperstimulation syndrome? 105 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Ovarian hyperstimulation syndrome have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.2% of all adverse event reports for LEUPROLIDE.
105
Reports of Ovarian hyperstimulation syndrome with LEUPROLIDE
0.2%
of all LEUPROLIDE reports
2
Deaths
49
Hospitalizations
How Dangerous Is Ovarian hyperstimulation syndrome From LEUPROLIDE?
Of the 105 reports, 2 (1.9%) resulted in death, 49 (46.7%) required hospitalization, and 6 (5.7%) were considered life-threatening.
Is Ovarian hyperstimulation syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Ovarian hyperstimulation syndrome?
CHORIOGONADOTROPIN ALFA (1,016)
FOLLITROPIN (718)
GANIRELIX (672)
TRIPTORELIN (356)
PROGESTERONE (293)
MENOTROPINS (238)
LUTROPIN ALFA (194)
GONADOTROPHIN, CHORIONIC (173)
FOLLITROPIN BETA (163)
FOLLITROPIN ALFA (138)
Which LEUPROLIDE Alternatives Have Lower Ovarian hyperstimulation syndrome Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM